Studies with purified DT-diaphorase have shown that the enzyme is capable of catalyzing a two-electron reduction of the novel indoloquinone E 0 9 to a DNA-damaging alkylating species. The aim of this study was to determine to what extent DT-diaphorase may be involved in the metabolic activation of E09 and mitomycin C in both aerobic and hypoxic conditions. Two human colon-carcinoma cell lines were used; H l 2 9 has high levels of DT-diaphorase whilst BE lacks this activity because of a point mutation in the NQOl gene. In aerobic conditions the 2 cell lines show similar sensitivities to a number of qtotoxic drugs including cisplatin, doxorubicin and etoposide. They are equally sensitive to the benzotriazine di-N-oxide SR 4233 but H R 9 is more sensitive than BE to mitomycin C and E09. Sensitivity to SR 4233 is increased by about 100-fold for both cell lines in hypoxic conditions. DT-diaphorase-deficient BE cells show markedly increased sensitivity to mitomycin C and particularly E 0 9 in hypoxic conditions, whereas DTdiaphorase-rich H R 9 cells show little hypoxic sensitization to these agents unless exposed in the presence of dicoumarol.These results suggest that DT-diaphorase can reduce E09 and mitomycin C to potent cytotoxic species in aerobic conditions, and this activii predominates over the one-electron-reducing enzymes even in hypoxic conditions. In the absence of DTdiaphorase activity, E 0 9 and mitomycin C are reduced in hypoxic conditions, presumably by one-electron-reducing enzymes, to a similar or greater extent than is achieved with DT-diaphorase.8 1994 Wfq-Liss, Znc.The presence of hypoxic areas in solid tumours suggests a target for the development of selective anti-cancer agents. The main classes of bioreductive agents which show specificity for hypoxic cells are quinone, nitro and N-oxide compounds (Workman, 1992). Hypoxic cell specificity is dependent on preferential metabolic activation by reductase enzymes in hypoxic conditions (Workman, 1992). Mitomycin C is the prototype bioreductive agent which shows clinical activity against some solid tumours but exhibits little selectivity towards hypoxic tumour cells (Stratford and Stephens, 1989; Workman, 1992). It (Oostveen and Speckamp, 1987) is structurally related to mitomycin C (Fig. l), is less myelosuppressive (Hendriks et al., 1993) and is in clinical trial in Europe under the auspices of the EORTC. E09 also requires metabolic activation and has been shown to be a much better substrate for both human and rat DT-diaphorase than mitomycin C (Walton et al., 1991).In hypoxic conditions one-electron reduction of quinone bioreductive agents by enzymes such as cytochrome P450 reductase and xanthine oxidase results in the production of semiquinone free radicals. However, in aerobic conditions toxic oxygen radicals are produced due to back oxidation of these unstable metabolites. In contrast, obligate two-electron reduction by DT-diaphorase (Iyanagi and Yamazaki, 1970) results in production of more stable hydroquinone metabolites under both aerobic an...